Archive for July, 2006

Tinnitus - The Deaf Resource Library

Monday, July 31st, 2006

The Deaf Resource Library Online collection of resource material and links intended to inform about deaf communities and resources Technorati Tags: tinnitus

Tags:
Tinnitus

Tinnitus - Technorati Tags: tinnitus

Monday, July 31st, 2006

Technorati Tags: tinnitus

Tags:
Tinnitus

Tinnitus - Clinical Trials Update: July 31, 2006 (HealthDay) HealthDay - (HealthDay

Monday, July 31st, 2006

Clinical Trials Update: July 31, 2006 (HealthDay) HealthDay - (HealthDay News) — Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Men at higher risk of recurrent blood clotsAmong people who have had blood clots, men are twice as likely as women to have them again after […]

A Top-Gear Drug for the Treatment of Pain and Inflammation

Monday, July 31st, 2006

LUGANO, Switzerland, July 31/PRNewswire/ —

New Evidences Confirm the Assets of Original Nimesulide(1):

Multifactorial Pharmacological Activity, Fast Analgesic Action,

Abbott’s HUMIRA(R) (Adalimumab) Receives FDA Approval for Treatment of Ankylosing Spondylitis

Monday, July 31st, 2006

- HUMIRA Now Approved to Treat Three Forms of Inflammatory Arthritis; Being Studied for Three Other Autoimmune Diseases -

ABBOTT PARK, Ill., July 31 /PRNewswire-FirstCall/ — Abbott (NYSE:ABT) announced today that the U.S. Food and Drug Administration (FDA) approved HUMIRA(R) (adalimumab) for reducing signs and symptoms in patients…

Re: Daily Challenge for 07-21-06

Monday, July 31st, 2006

I’ll be starting the daily challenge again tomorrow.

We’ve had some family issues that have had us very busy.

Jen

Issues with the Site

Monday, July 31st, 2006

For those who are wondering what in the world happened this morning - my email did not get hijacked. Notification of instant messages is sent from my server - which is why the email that you received this morning had my name on it.

A registered…

Receptor BioLogix Acquires Late-Stage Cancer Drug from Aphton Corp.

Monday, July 31st, 2006

Insegia(TM) Immunotherapeutic for Pancreatic and Stomach Cancers

SOUTH SAN FRANCISCO, Calif., July 31 /PRNewswire/ — Receptor BioLogix, Inc., a privately held biopharmaceutical company focused on development of cancer drugs, announced today that it has acquired the cancer vaccine Insegia(TM), and related assets, from Philadelphia-based Aphton Corp. (Pink Sheet:…

Singapore’s DSO National Laboratories to Study ImmuneRegen’s Viprovex(TM)

Monday, July 31st, 2006

ImmuneRegen Product to be Tested as Defense to Potential Biological Weapon

SCOTTSDALE, Ariz., July 31 /PRNewswire-FirstCall/ — ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (BULLETIN BOARD: IRBO) , will partner with Singapore’s Defense Medical & Environmental Research Institute, DSO National Laboratories, to launch…

Digene Announces Ruling In Arbitration With Beckman Coulter

Monday, July 31st, 2006

GAITHERSBURG, Md., July 31 /PRNewswire-FirstCall/ — Digene Corp. (NASDAQ:DIGE) today announced that the International Centre for Dispute Resolution of the American Arbitration Association ruled in Digene’s favor in its arbitration with Beckman Coulter, Inc. The arbitration related to the Sept. 25, 2002, announcement by Ventana Medical Systems, Inc. that it…